Markets Featured

Can America's Empty Offices Really Become Apartments?

America's largest office-to-residential conversion nearly collapsed this week. The trade that was supposed to fix both the office glut and the housing shortage just got its first real stress test — and the risk premium is repricing.

Alpha One

08 Jul 2026 • 7 min read

On Tuesday morning, two steel columns on the 21st floor of the former Pfizer headquarters in Midtown Manhattan began to bend. By 8 a.m., the FDNY had drawn a collapse zone from First Avenue to Third Avenue and evacuated the 37-story tower along with the buildings around it, a few hundred feet from Grand Central Terminal. Fire inspectors found two buckled columns and sagging floors between the 21st and 26th levels. Mayor Zohran Mamdani told reporters the building "remains unstable." No one was hurt. Crews spent the rest of the day racing steel shoring into the structure, and by evening officials said it had stopped moving.

Here is why this is more than a local news story: 235 East 42nd Street is not just any construction site. Together with its sister building next door at 219 East 42nd, it is the largest office-to-residential conversion in American history — more than 1,600 apartments, including over 400 affordable units, carved out of Pfizer's old corporate campus. It is the flagship project of the single most popular idea in American real estate right now: that the country's emptiest asset class can be turned into its scarcest one.

That idea just had its first public stress test. Investors should pay attention to what it revealed.

The most crowded trade in real estate

The pitch behind office-to-residential conversion is elegant. The United States has a glut of office space — remote work hollowed out central business districts and left landlords holding towers worth a fraction of their pre-2020 marks. It also has a housing shortage measured in millions of units nationally, at its most acute in exactly the cities where the empty offices stand. One trade, two crises solved: buy the distressed tower, gut it, rent the apartments.

The money has followed. The national pipeline of office-to-apartment conversions reached roughly 90,300 units at the start of 2026, up 28% in a year, according to RentCafe's analysis of Yardi Matrix data. New York leads the country with more than 16,000 units in the works. Developers in the city are on track to start roughly 9.5 million square feet of conversions this year — more than double last year's 4.3 million, and nearly twice the previous record set in 2008.

None of this happened spontaneously. New York State's 467-m tax abatement dangles up to a 35-year property tax exemption for conversions that include affordable units — and it required projects to secure change-of-use permits by June 2026 to capture the full benefit. That deadline, which passed five weeks ago, triggered exactly the race you would expect: a cohort of enormous, complex projects all sprinting through permitting at once. The city's rezoning of Midtown and its "City of Yes" reforms widened the pipe further. Falling office values did the rest.

The Pfizer project is the template. David Werner and Metro Loft's Nathan Berman — the developer who more or less invented the Manhattan conversion playbook in the Financial District — assembled the two 1970s-era towers, lined up a $75 million acquisition loan from Northwind Group in 2024, and closed a $720 million construction loan from Madison Realty Capital in May 2025. At more than 1,600 units, it would surpass the 1,320-unit SoMA conversion at 25 Water Street as the biggest in the country. Completion was targeted for 2027.

Briefings like this land in members' inboxes before the market prices them in. Join free →

Conversion is surgery, not renovation

What Tuesday exposed is the part of the conversion story the pipeline numbers don't capture: this is the hardest kind of construction there is.

An office tower and an apartment building are different machines. Office floor plates are deep — designed to put as many desks as possible between the elevator core and the windows. Apartments need light and air in every unit, which means carving light wells and courtyards through the middle of the structure. Plumbing, ventilation, and electrical systems have to be rebuilt from scratch. And because the economics rarely work on the existing square footage alone, developers routinely add floors on top — increasing loads on a 50-year-old frame at the same time they are cutting structural members out of it.

That is precisely the combination at 235 East 42nd Street. The project involves both gut renovation and vertical expansion; the sister tower at 219 East 42nd topped out its added floors about eight months ago. Construction attorney and industry expert Barry LePatner told Commercial Observer that the buckling pattern suggested renovation work had "taken down certain structural members," weakening a large section of the building. The Department of Buildings had already cited the project for violations last year, The Real Deal reported. The investigation will take months, and it is too early to assign cause. But the structural risk profile of this kind of work is not a mystery — it is the reason conversions were a niche specialty for decades before they became a movement.

The physics has a financial mirror. Conversion deals pencil only when three things line up: a distressed purchase basis, a tax abatement, and construction debt priced for a project that finishes on time. Remove any leg and the stool falls. Which is why the marginal lender to this boom is not a bank — it is private credit. Madison Realty Capital's $720 million loan on the Pfizer project is the largest conversion construction loan in the city. Debt funds are underwriting a construction typology with fat contingencies and, until this week, a clean public track record.

What one near-miss changes

Nobody died on Tuesday, and the building did not fall. In the counterfactual where those columns failed at 3 a.m. instead of bending slowly during a workday, every conversion project in America would be stopped today. What actually happened is subtler: the risk premium on adaptive reuse just repriced.

Expect three concrete effects. First, scrutiny: the DOB will crawl through every major conversion site in the city, and permit timelines — the binding constraint for the 467-m cohort that just rushed in before the June deadline — will stretch. Second, insurance and financing: builder's risk premiums on structural-alteration projects were already brutal; a headline near-collapse at the flagship project gives every underwriter and credit committee a fresh exhibit. Higher contingencies and tighter covenants flow straight through to which deals pencil. Third, selectivity: the gap between specialist operators with thirty years of conversion scar tissue and the tourists who arrived for the tax abatement is about to become very visible.

There is also a quieter implication for the office market itself. Over the past two years, "worst case, it converts" has functioned as a soft floor under distressed office valuations — the assumption that residential demand stands ready to absorb any tower that trades cheaply enough. That floor is real, but Tuesday showed it is conditional. Conversion capacity is constrained by engineering, insurance, and a finite bench of operators who can actually execute. If the implied conversion bid weakens, the buildings that were marginal candidates — wrong floor plates, wrong bones, wrong basis — lose their bid entirely. That discount lands on the office loan books we have written about before, at exactly the moment a record volume of CRE debt is rolling over.

The uncomfortable housing math

The final thing worth internalizing is what conversions can and cannot fix. New York's comptroller estimates the current qualifying wave could produce roughly 14,500 apartments in Manhattan south of 59th Street — about 3,600 of them income-restricted. That is genuinely useful. It is also a rounding error against a citywide housing deficit measured in the hundreds of thousands of units. Even a record conversion boom, executed flawlessly, does more to heal the office market than the housing market: it removes obsolete supply from one column and adds a modest number of expensive-to-build units to the other.

That asymmetry matters for how you read the politics. The tax abatements and rezonings that power this boom are sold as housing policy. They are closer to office-market triage with a housing dividend. Both are legitimate goals — but the investor takeaway is that the conversion wave's durability depends on political patience with a program whose housing yield is structurally small. A visible safety failure is precisely the kind of event that tests that patience.

The bottom line

Watch three things from here. One: the DOB's findings on 42nd Street and whether they trigger new structural-review requirements for alteration permits — that is the variable that moves every project's timeline in the city. Two: the terms on the next major conversion construction loan; private credit's appetite, more than any zoning map, decides how big this wave gets. Three: the 467-m rush cohort — the projects that raced through permitting before June 2026 now have to actually deliver, and they will do it under more scrutiny, with more expensive insurance, than the deals underwritten even two months ago.

The conversion trade is not dead — the underlying arbitrage between empty offices and scarce housing is real, and the specialists who survive this repricing will face less competition, not more. But the era when a record pipeline could be read as a record opportunity ended at 8 a.m. on Tuesday, twenty-one floors above 42nd Street.

If this analysis was useful, this is what AlphaBriefing does every day — geopolitics and markets, connected to what it means for your money. Free members get the daily brief in their inbox; paid members get the investment frameworks, scenario pricing, and catalyst calendars behind the paywall.

Sign up free → — upgrade whenever it earns it.

Get this level of intelligence every day. Subscribe to AlphaBriefing — free, member, and paid tiers available.

Sources & Further Reading

Disclaimer

AlphaBriefing is an independent intelligence publication. The content in this article is produced for informational and educational purposes only. Nothing published by AlphaBriefing constitutes financial, investment, legal, tax, or regulatory advice, nor should it be construed as a solicitation or recommendation to buy, sell, or hold any security, asset, or financial instrument.

All views expressed are those of the author at the time of writing and are subject to change without notice. Markets are volatile and unpredictable; past performance is not indicative of future results. Any investment involves risk, including the possible loss of principal.

AlphaBriefing and its principals, employees, or contributors may hold positions in securities or assets mentioned in this article. This should be considered a potential conflict of interest. No material relationship with any company referenced exists unless explicitly disclosed. Readers should conduct their own due diligence and consult qualified financial, legal, and tax advisors before making any investment decisions.

Information in this article is drawn from public sources believed to be reliable at the time of publication. AlphaBriefing makes no warranty, express or implied, as to the accuracy, completeness, or timeliness of any information herein. AlphaBriefing accepts no liability for any loss or damage arising from reliance on this content.